CAMBRIDGE, MA, Biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, closed a $52 million Series C financing. Read More
CAMBRIDGE, MA, Clinical-stage biopharmaceutical company developing tumor-targeted and immuno-oncology therapies announced a $100 million financing. Read More
CHICAGO, IL, Social impact startup focused on prison and jail education and communication, has closed their A-3 raise with over $9M in funding. Read More